Insignificant role of the N-terminal cobalt-binding site of albumin in the assessment of acute coronary syndrome: discrepancy between the albumin cobalt-binding assay and N-terminal-targeted immunoassay

References

• Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine. (2007). ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116:e148–e304.
   PubMed Web of Science ®Google Scholar
• Antman EM, Grudzien C, Sacks DB. (1995). Evaluation of a rapid bedside assay for detection of serum cardiac troponin T. JAMA 273:1279–1282.
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Lau E, Winkler JV. (2000). A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 19:311–315.
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Rael LT, Bar-Or R, Slone DS, Craun ML. (2006). The formation and rapid clearance of a truncated albumin species in a critically ill patient. Clin Chim Acta 365:346–349.
   Google Scholar
• Bar-Or D, Rael LT, Bar-Or R, Slone DS, Mains CW, Rao NK, Curtis CG. (2008). The cobalt-albumin binding assay: insights into its mode of action. Clin Chim Acta 387:120–127.
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. (2001). Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 141:985–991.
   PubMed Web of Science ®Google Scholar
• Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, Honda SA, Rios CN, Sugiyama CE, Ha CE. (2003). Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 49:581–585.
   PubMed Web of Science ®Google Scholar
• Cho DK, Choi JO, Kim SH, Choi J, Rhee I, Ki CS, Lee SC, Gwon HC. (2007). Ischemia-modified albumin is a highly sensitive serum marker of transient myocardial ischemia induced by coronary vasospasm. Coron Artery Dis 18:83–87.
   Google Scholar
• Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, Branham E, Apple FS, Murakami M, Morris DL. (2001). Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 47:464–470.
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P. (2010). Current role of ischemia-modified albumin in routine clinical practice. Biomarkers 15:655–662.
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P, Jimenez-Sosa A, Samimi-Fard S, Idaira HB. (2009). Does ischemia-modified albumin add prognostic value to the Thrombolysis In Myocardial Infarction risk score in patients with ST-segment elevation myocardial infarction treated with primary angioplasty? Biomarkers 14:43–48.
   PubMed Web of Science ®Google Scholar
• Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB, Loro VL, Schetinger MR. (2009). Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 42:666–671.
   PubMed Web of Science ®Google Scholar
• Hjortshoj S, Kristensen SR, Ravkilde J.. (2010). Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome. Am J Emerg Med 28:170–176.
   PubMed Web of Science ®Google Scholar
• Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, Katus H. (2000). It’s time for a change to a troponin standard. Circulation 102:1216–1220.
   PubMed Web of Science ®Google Scholar
• Kazanis K, Dalamaga M, Nounopoulos C, Manolis AS, Sakellaris N, Jullien G, Dionyssiou-Asteriou A. (2009). Ischemia modified albumin, high-sensitivity c-reactive protein and natriuretic peptide in patients with coronary atherosclerosis. Clin Chim Acta 408:65–69.
   PubMed Web of Science ®Google Scholar
• Keating L, Benger JR, Beetham R, Bateman S, Veysey S, Kendall J, Pullinger R. (2006). The PRIMA study: presentation ischaemia-modified albumin in the emergency department. Emerg Med J 23:764–768.
   PubMedGoogle Scholar
• Kim JS, Hwang HJ, Ko YG, Choi D, Ha JW, Hong MK, Jang Y.. (2010). Ischemia-modified albumin: is it a reliable diagnostic and prognostic marker for myocardial ischemia in real clinical practice?. Cardiology 116:123–129.
   Google Scholar
• Lippi G, Montagnana M, Salvagno GL, Guidi GC. (2007). Standardization of ischemia-modified albumin testing: adjustment for serum albumin. Clin Chem Lab Med 45:261–262.
   PubMed Web of Science ®Google Scholar
• Morrow DA, de Lemos JA, Sabatine MS, Antman EM. (2003). The search for a biomarker of cardiac ischemia. Clin Chem 49:537–539.
   PubMed Web of Science ®Google Scholar
• Mothes E, Faller P. (2007). Evidence that the principal CoII-binding site in human serum albumin is not at the N-terminus: implication on the albumin cobalt binding test for detecting myocardial ischemia. Biochemistry 46:2267–2274.
   PubMed Web of Science ®Google Scholar
• Peacock F, Morris DL, Anwaruddin S, Christenson RH, Collinson PO, Goodacre SW, Januzzi JL, Jesse RL, Kaski JC, Kontos MC, Lefevre G, Mutrie D, Sinha MK, Uettwiller-Geiger D, Pollack CV. (2006). Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 152:253–262.
   PubMed Web of Science ®Google Scholar
• Piwowar A, Knapik-Kordecka M, Warwas M. (2008). Ischemia-modified albumin level in type 2 diabetes mellitus - Preliminary report. Dis Markers 24:311–317.
   PubMed Web of Science ®Google Scholar
• Puleo PR, Meyer D, Wathen C, Tawa CB, Wheeler S, Hamburg RJ, Ali N, Obermueller SD, Triana JF, Zimmerman JL. (1994). Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med 331:561–566.
   PubMed Web of Science ®Google Scholar
• Reiter M, Twerenbold R, Reichlin T, Haaf P, Peter F, Meissner J, Hochholzer W, Stelzig C, Freese M, Heinisch C, Breidthardt T, Freidank H, Winkler K, Campodarve I, Gea J, Mueller C. (2011). Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J 32:1379–1389.
   PubMed Web of Science ®Google Scholar
• Rioufol G, Finet G, Ginon I, André-Fouët X, Rossi R, Vialle E, Desjoyaux E, Convert G, Huret JF, Tabib A. (2002). Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 106:804–808.
   PubMed Web of Science ®Google Scholar
• Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R, Gaze D, Collinson P, Carlos Kaski J. (2004). Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 97:297–301.
   PubMed Web of Science ®Google Scholar
• Sbarouni E, Georgiadou P, Theodorakis GN, Kremastinos DT. (2006). Ischemia-modified albumin in relation to exercise stress testing. J Am Coll Cardiol 48:2482–2484.
   PubMed Web of Science ®Google Scholar
• Sbarouni E, Georgiadou P, Voudris V. (2011). Gender-specific differences in biomarkers responses to acute coronary syndromes and revascularization procedures. Biomarkers 16:457–465.
   PubMed Web of Science ®Google Scholar
• Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. (2004). Role of “Ischemia modified albumin”, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21:29–34.
   PubMed Web of Science ®Google Scholar
• Sokolowska M, Wszelaka-Rylik M, Poznanski J, Bal W. (2009). Spectroscopic and thermodynamic determination of three distinct binding sites for Co(II) ions in human serum albumin. J Inorg Biochem 103:1005–1013.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. (2007). Universal definition of myocardial infarction. Eur Heart J 28:2525–2538.
   PubMed Web of Science ®Google Scholar